{"id":1799,"date":"2022-04-11T18:18:08","date_gmt":"2022-04-11T18:18:08","guid":{"rendered":"https:\/\/healthtech.berkeley.edu\/?page_id=1799"},"modified":"2022-04-11T18:18:55","modified_gmt":"2022-04-11T18:18:55","slug":"ocuelar","status":"publish","type":"page","link":"https:\/\/diagnostic.berkeley.edu\/index.php\/ocuelar\/","title":{"rendered":"Ocuelar"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Ocuelar<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

In 2014, the chief medical officer of an LLC called 231 Sheep noticed many of his Bay Area ophthalmology patients didn\u2019t take their glaucoma medications properly and were losing their sight. The disease, which is not curable but manageable with eye drops, is the world\u2019s leading cause of irreversible blindness, but 60 percent of patients don\u2019t take their eye drops as frequently as necessary and are paying the price for it. <\/span><\/p>


<\/span><\/p>\n

<\/p>\n

231 Sheep created <\/span>Ocuelar<\/span><\/a>, a now-patented innovation. Allan Lee and Varun Shravah, project managers and clinical leadsm selected six Berkeley master\u2019s students to develop a device: Aakansha Gosain (bioengineering), Andrew Flach (mechanical engineering), Chichi Chang (bioengineering), Manish Singh (biomedical engineering), Ryan Young (bioengineering), and Yifan Mao (mechanical engineering). <\/span><\/p>


<\/span><\/p>\n

<\/p>\n

Ocuelar uses a next-generation, nanotechnology-based hardware with a variety of sensors to record a patient\u2019s medication usage in real-time. AI software and machine learning allows the device to identify at-risk glaucoma patients and predict their medication behavior. The result will be more accurate data for clinicians, earlier detection, and lower costs and better vision for patients.<\/span><\/p>


<\/span><\/p>\n

<\/p>\n

\u201cGlaucoma is an insidious disease that disproportionately impacts people of color and minorities, specifically African-Americans, Latinos, and East Asians,\u201d says Varun. \u201cNot only are people from these communities more at risk for the disease, they also tend to have worse outcomes. We wanted to build Ocuelar in a space that is dedicated to helping to reduce some of the healthcare disparities that exist for communities of color.\u201d<\/span><\/p>\n

<\/p>\n

In the CoLab, the team looks forward to collaborating and discussing ideas with other students and teams in order to refine its own ideas and create a user-centric device.<\/span><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Ocuelar In 2014, the chief medical officer of an LLC called 231 Sheep noticed many of his Bay Area ophthalmology patients didn\u2019t take their glaucoma medications properly and were losing their sight. The disease, which is not curable but manageable with eye drops, is the world\u2019s leading cause of irreversible blindness, but 60 percent of […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-1799","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nOcuelar - UC Berkeley Health Tech CoLab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocuelar - UC Berkeley Health Tech CoLab\" \/>\n<meta property=\"og:description\" content=\"Ocuelar In 2014, the chief medical officer of an LLC called 231 Sheep noticed many of his Bay Area ophthalmology patients didn\u2019t take their glaucoma medications properly and were losing their sight. The disease, which is not curable but manageable with eye drops, is the world\u2019s leading cause of irreversible blindness, but 60 percent of […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/\" \/>\n<meta property=\"og:site_name\" content=\"UC Berkeley Health Tech CoLab\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-11T18:18:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/\",\"url\":\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/\",\"name\":\"Ocuelar - UC Berkeley Health Tech CoLab\",\"isPartOf\":{\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#website\"},\"datePublished\":\"2022-04-11T18:18:08+00:00\",\"dateModified\":\"2022-04-11T18:18:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/diagnostic.berkeley.edu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocuelar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#website\",\"url\":\"https:\/\/diagnostic.berkeley.edu\/\",\"name\":\"Health Tech CoLab - UC Berkeley\",\"description\":\"Facilitating healthcare in low-resource settings. \",\"publisher\":{\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/diagnostic.berkeley.edu\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#organization\",\"name\":\"Health Tech CoLab\",\"url\":\"https:\/\/diagnostic.berkeley.edu\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/healthtech.berkeley.edu\/wp-content\/uploads\/2021\/09\/landing_new-v2-06.svg\",\"contentUrl\":\"https:\/\/healthtech.berkeley.edu\/wp-content\/uploads\/2021\/09\/landing_new-v2-06.svg\",\"width\":1266,\"height\":1253,\"caption\":\"Health Tech CoLab\"},\"image\":{\"@id\":\"https:\/\/diagnostic.berkeley.edu\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ocuelar - UC Berkeley Health Tech CoLab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/","og_locale":"en_US","og_type":"article","og_title":"Ocuelar - UC Berkeley Health Tech CoLab","og_description":"Ocuelar In 2014, the chief medical officer of an LLC called 231 Sheep noticed many of his Bay Area ophthalmology patients didn\u2019t take their glaucoma medications properly and were losing their sight. The disease, which is not curable but manageable with eye drops, is the world\u2019s leading cause of irreversible blindness, but 60 percent of […]","og_url":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/","og_site_name":"UC Berkeley Health Tech CoLab","article_modified_time":"2022-04-11T18:18:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/","url":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/","name":"Ocuelar - UC Berkeley Health Tech CoLab","isPartOf":{"@id":"https:\/\/diagnostic.berkeley.edu\/#website"},"datePublished":"2022-04-11T18:18:08+00:00","dateModified":"2022-04-11T18:18:55+00:00","breadcrumb":{"@id":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/healthtech.berkeley.edu\/index.php\/ocuelar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/diagnostic.berkeley.edu\/"},{"@type":"ListItem","position":2,"name":"Ocuelar"}]},{"@type":"WebSite","@id":"https:\/\/diagnostic.berkeley.edu\/#website","url":"https:\/\/diagnostic.berkeley.edu\/","name":"Health Tech CoLab - UC Berkeley","description":"Facilitating healthcare in low-resource settings. ","publisher":{"@id":"https:\/\/diagnostic.berkeley.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diagnostic.berkeley.edu\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/diagnostic.berkeley.edu\/#organization","name":"Health Tech CoLab","url":"https:\/\/diagnostic.berkeley.edu\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/diagnostic.berkeley.edu\/#\/schema\/logo\/image\/","url":"https:\/\/healthtech.berkeley.edu\/wp-content\/uploads\/2021\/09\/landing_new-v2-06.svg","contentUrl":"https:\/\/healthtech.berkeley.edu\/wp-content\/uploads\/2021\/09\/landing_new-v2-06.svg","width":1266,"height":1253,"caption":"Health Tech CoLab"},"image":{"@id":"https:\/\/diagnostic.berkeley.edu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/pages\/1799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/comments?post=1799"}],"version-history":[{"count":4,"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/pages\/1799\/revisions"}],"predecessor-version":[{"id":1803,"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/pages\/1799\/revisions\/1803"}],"wp:attachment":[{"href":"https:\/\/diagnostic.berkeley.edu\/index.php\/wp-json\/wp\/v2\/media?parent=1799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}